Advertisement

Topics

Exiqon Company Profile

04:06 EDT 17th October 2017 | BioPortfolio

Exiqon operates in two business segments sharing one vision: the idea of taking science to patients through personalized medicine; one focus: the promise of miRNA as biological markers; and one technology platform: our proprietary LNA(TM) (Locked Nucleic Acid) detection technology with its unique competitive advantages in the markets we address. Exiqon Life Sciences has established a position for itself as one of the market's leading providers of research products for gene expression analysis. Our products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries in the field of gene expression analysis. Exiqon Life Sciences is also collaborating with pharmaceutical companies in their effort to develop new medicines based on biological markers (Pharma Services). Exiqon Diagnostics is a leading provider of cellular based diagnostics for cancer treatment selection. We are developing a series of new molecular diagnostic tests for high incidence cancers based on miRNA biomarkers. The first test has been developed, and additional tests are in the pipeline for each coming year. Exiqon has approximately 170 employees and is listed on the NASDAQ OMX in Copenhagen. For more information about Exiqon, visit www.exiqon.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

Exiqon AS Product Pipeline Analysis, 2017 Update [Report Updated: 08062017] Prices from USD $750

SummaryExiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include mic...

Exiqon AS Medical Equipment Deals and Alliances Profile [Report Updated: 12072017] Prices from USD $250

SummaryExiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include mic...

Exiqon AS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryExiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include mic...

Drugs and Medications [0 Results]

None

PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population.

Type 2 diabetes mellitus (T2DM) is characterized by islet β-cell dysfunction and insulin resistance, which leads to an inability to maintain blood glucose homeostasis. Circulating microRNAs (miRNAs) ...

A panel of microRNA signature in serum for colorectal cancer diagnosis.

Dysregulated expression of specific microRNAs (miRNAs) in serum has been recognised as promising diagnostic biomarkers for colorectal cancer (CRC). In the initial screening phase, a total of 32 differ...

Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.

At least seven studies have suggested that microRNA levels in whole blood can be diagnostic for lung cancer. We conducted a large bi-institutional study to validate this. Qiagen® PAXgene™ Blood miR...

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.

The differential expression of microRNAs (miRNAs) in plasma of esophageal squamous cell carcinoma (ESCC) patients may serve as a diagnostic biomarker. A four-stage study was conducted to identify plas...

Screening and confirmation of microRNA markers for distinguishing between menstrual and peripheral blood.

The identification of menstrual blood (MB) and peripheral blood (PB) left at a crime scene is crucial for crime reconstruction, especially in sexual assaults. MicroRNAs (miRNAs), a class of non-protei...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Exiqon

Exiqon operates in two business segments sharing one vision: the idea of taking science to patients through personalized medicine; one focus: the promise of miRNA as biological markers; and one techno...

Exiqon A/S

Exiqon A/S focused on the development of novel DNA and immunodiagnostic products against common genetic diseases, in particular, cardiovascular, diabetic and other chronic and degenerative diseases.

Exiqon A/

Exiqon is the global provider of Locked Nucleic Acid (LNA™) and a leading supplier of high-value gene expression analysis products and web-based software tools to help scientists achieve rapid and r...

More Information about "Exiqon" on BioPortfolio

We have published hundreds of Exiqon news stories on BioPortfolio along with dozens of Exiqon Clinical Trials and PubMed Articles about Exiqon for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Exiqon Companies in our database. You can also find out about relevant Exiqon Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record